In vitro assessment of platelet storage lesion in leucoreduced random donor platelet concentrates

Blood Transfusion

Volumn 8, Issue 1, 2010, Pages 28-35

  Ahmed, Amal Sayed ^a   Leheta, Ola ^a   Younes, Soha ^a  

^a Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

CD62P; Platelet concentrate; Platelet storage lesion; sHLA 1

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; HLA ANTIGEN; HLA ANTIGEN CLASS 1; THROMBOCYTE CONCENTRATE;

ARTICLE; BLOOD CELL; BLOOD COMPONENT; BLOOD FILTRATION; BLOOD TRANSFUSION REACTION; CELL FUNCTION; CENTRIFUGATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FILTER; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; IN VITRO STUDY; LEUKOCYTE; LYMPHOCYTE; QUALITY CONTROL; SAFETY; STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; THROMBOCYTE PRESERVATION;

BLOOD PLATELETS; HUMANS; P-SELECTIN; PLATELETPHERESIS; PRESERVATION, BIOLOGICAL; STRESS, PHYSIOLOGICAL; TIME FACTORS;

EID: 74549220392     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2009.0077-09     Document Type: Article

References (35)

1. Wallace EL, Churchill WH, Surgenor DM, Cho GS. Collection and transfusion of blood and blood components in the United States, 1994. Transfusion 1998; 38:625-36.
2. Klinger MH. The storage lesion of ultrastructural and functional aspects. Ann Hematol 1996; 73:103-12.
3. Seghatchian J, Krailadsiri P. Platelet storage lesion and apoptosis: are they related? Transfus Apheresis Sci 2001; 24:103-5 [Review].
4. Seghatchian J, Krailadsiri P. The platelet storage lesion. Transfus Med Rev 1997; 11:130-44.
5. Krailadsiri P, Seghatchian J, Williamson LM. Platelet storage lesion of WBC-reduced pooled buffy coat-derived PC prepared in three in-process filtered/storage bag combinations. Transfusion 2001; 41:243-50.
6. Bordin JO, Heddle NM, Blajchman MA. Biological effects of leukocytes present in transfused cellular blood products. Blood 1994; 84:1703-21.
7. Murphy S, Rebulla P, Bertolini F. In vitro assessment of the quality of stored platelet concentrates. The BEST (Biomedical Excellence for Safer Transfusion) Task Force of the International Society of Blood Transfusion. Transfus Med Rev 1994; 8:29-36.
8. Vostal JG. FDA guidance for industry: for platelet testing and evaluation of platelet substitute products. Presented at the 18th meeting of the BEST Working Party of the International Society of Blood Transfusion, San Francisco, and November 5, 1999.
9. Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996; 87:4925-36.
10. Triulzi DJ, Kickler TS, Braine HG. Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis. Transfusion 1992; 32:529-33.
11. Rinder HM, Murphy M, Mitchell JG. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991; 31:409-14.
12. Dumont LJ, AuBuchon JP, Whitley P. Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion 2002; 42:847-54.
13. Rinder HM, Smith BR. In vitro evaluation of platelets: is there hope for predicting posttransfusion platelet survival and function? Transfusion 2003; 43:2-6.
14. Leytin V, Allen DJ, Gwozdz A, Garvey B. Role of platelet surface glycoprotein Ibá and P-selectin in the clearance of transfused platelet concentrates. Transfusion 2004; 44: 1486-95.
15. Ghio M, Contini P, Mazzei C. Soluble HLA class 1, HLA class 11 and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogenic blood transfusion. Blood 1999; 93:1770-7.
16. Nicolle MW, Nag B, Sharma SD, et al. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD41 lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J Clin Invest 1994; 93:1361-9.
17. Zavazava N, Kronke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med 1996; 2:1005-10.
18. Sayegh MH, Carpenter CB. Role of indirect allorecognition in allograft rejection. Int Rev Immunol 1996; 13: 221-9.
19. Seghatchian J. Universal leucodepletion: an overview of some unresolved issues and the highlights of lesson learned. Transfus Apheresis Sci 2003; 20:105-17.
20. Slichter SJ, Harker LA. Preparation and storage of platelet concentrates. 1. Factors influencing the harvest of viable platelet from whole blood. Br J Haematol 1976; 39:395-402.
21. Moroff G, Dich J, Dabay M. Validation of use of the Nogeotte hemocytometer to count low levels of white cells reduced platelet components. Transfusion 1994; 34:35-8.
22. Bertolini F. Murphy S. A multicenter evaluation of reproducibility of swirling in platelet concentrates. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion. Transfusion 1994; 34:796-801.
23. Slichter SJ. Controversies in platelet transfusion therapy. Ann Rev Med 1980; 31:509-40.
24. Krailadsiri P, Seghatchian J, Amiral J. Annexin V. A maker of platelet storage lesion: correlation with dMPV. Transfus Science 1997; 18:223-6.
25. Pedigo M, Wun T, Paglieroni T. Removal by white cell-reduction filters of activated platelets expressing CD62. Transfusion 1993; 11:930-5.
26. Curvers J, van Pampus EC, Feijge MA, et al. Decreased responsiveness and development of activated markers of PLTs stored in plasma. Transfusion 2004; 44:49-58.
27. Perrotta PL, Perrotta CL, Synder EL. Apoptotic activity in stored human platelets. Transfusion 2003; 43:526-35.
28. Seghatchian J. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers. Transfus Apheresis Sci 2006; 34:125-30.
29. Michelson AD, Barnard MR, Hechtmant HB. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93:11877-82.
30. Chong BH, Murray B, Berndt MC, et al. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 1994; 83:1535-41.
31. Mincheff M. Changes in donor leukocytes during blood storage. Implications on post-transfusion immunomodulation and transfusion-associated GVHD. Vox Sang 1998;74(suppl 2):189-200.
32. Kao KJ, Scornik JC, Riley WJ, McQueen CF. Association between HLA phenotype and HLA concentration in plasma or platelets. Hum Immunol 1988; 21:115-24.
33. Krailadsiri P, Seghatchian J, Macgregor I et al. The effects of leukodepletion on the generation and removal of microvesicles and prion-protein in blood components. Transfusion 2006; 46:407-17.
34. Westhoff U, Grosse Wilde H. Soluble HLA class I and class II concentrations in factor VIII and PCC preparations. Vox Sang 1995; 68:73-6.
35. Dzik S, Szuflad P, Eaves S. HLA antigens on leukocyte fragments and plasma proteins: prestorage leukoreduction by filtration. Vox Sang 1994; 66:104-11.